Abstract
We assessed the prevalence and correlates of alcohol use among 870 people who inject drugs living with HIV in Kenya, with attention toward (1) sexual and injecting risk behaviors for HIV transmission and (2) HIV care engagement. We defined heavy alcohol use as > 14 drinks/week for men and > 7 drinks/week for women, moderate alcohol use as any lesser but non-zero amount, and any alcohol use as either moderate or heavy use. Approximately 39% of participants reported any alcohol use and 15% heavy use. In multivariate analysis, any alcohol use compared to no use was associated with needle sharing, > 3 new sex partners in the past 3 months, being unaware of HIV status, never enrolling in HIV care, and not being on ART (all p < 0.05). Heavy alcohol use as compared to no use was associated with needle sharing (aOR = 2.72; 95% CI 1.43, 5.13), injection equipment sharing (aOR = 1.80; 95% CI 1.00, 3.16), > 3 new sex partners in the past 3 months (aOR = 1.99; 95% CI 1.12, 3.49), and being unaware of HIV status (aOR = 2.77; 95% CI 1.46, 5.19). There was no association between any measure of alcohol use and unsuppressed viral load. Alcohol use among people who inject drugs living with HIV may carry elevated risk of HIV transmission mediated by sexual and injecting practices and is associated with lower engagement in multiple stages of the HIV care cascade.
Similar content being viewed by others
Data Availability
The datasets generated and/or analyzed during the current study are not publicly available because the local ethics review committee requires oversight of use of research data but are available from the corresponding author on reasonable request.
Code Availability
Not applicable.
References
Degenhardt L, et al. Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review. Lancet Glob Health. 2017;5(12):e1192–207.
Mathers BM, et al. Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review. Lancet. 2008;372(9651):1733–45.
National AIDS, Control Programme STI. KENPHIA 2018 preliminary Report. NASCOP: Nairobi; 2020.
National AIDS, Control Programme STI. Kenya Most at Risk populations size Estimate Consensus. NASCOP: Nairobi; 2013.
Kurth AE, et al. Prevalence, estimated incidence, and risk behaviors among people who inject drugs in Kenya. J Acquir Immune Defic Syndr. 2015;70(4):420–7.
Brodish P, et al. Evidence of high-risk sexual behaviors among injection drug users in the Kenya PLACE study. Drug Alcohol Depend. 2011;119(1–2):138–41.
Oguya FO, et al. Rapid situational assessment of people who inject drugs (PWID) in Nairobi and coastal regions of Kenya: a respondent driven sampling survey. BMC Public Health. 2021;21(1):1549.
Musyoki H, et al. A decade and beyond: learnings from HIV programming with underserved and marginalized key populations in Kenya. J Int AIDS Soc. 2021;24(Suppl 3):e25729.
Powell A, et al. Subjective executive function deficits in hazardous alcohol drinkers. J Psychopharmacol. 2021;35(11):1375–85.
Le Marchand C, et al. Hazardous alcohol consumption among young adult IDU and its association with high risk behaviors. Drug Alcohol Depend. 2013;127(1–3):143–9.
Fisher JC, Bang H, Kapiga SH. The association between HIV infection and alcohol use: a systematic review and meta-analysis of african studies. Sex Transm Dis. 2007;34(11):856–63.
Noroozi M, et al. Effect of Alcohol Use on Injection and sexual behavior among people who inject drugs in Tehran, Iran: a coarsened exact matching Approach. J Res Health Sci. 2018;18(2):e00416.
Scott-Sheldon LA, et al. Alcohol use and sexual risk behaviors among individuals infected with HIV: a systematic review and meta-analysis 2012 to early 2013. Curr HIV/AIDS Rep. 2013;10(4):314–23.
Matos TD, et al. HIV risk behaviors and alcohol intoxication among injection drug users in Puerto Rico. Drug Alcohol Depend. 2004;76(3):229–34.
Stein MD, et al. Alcohol use patterns predict high-risk HIV behaviors among active injection drug users. J Subst Abuse Treat. 2000;18(4):359–63.
Rees V, et al. Association of alcohol consumption with HIV sex- and drug-risk behaviors among drug users. J Subst Abuse Treat. 2001;21(3):129–34.
Vagenas P, et al. The impact of Alcohol Use and Related Disorders on the HIV Continuum of Care: a systematic review: Alcohol and the HIV Continuum of Care. Curr HIV/AIDS Rep. 2015;12(4):421–36.
Azar MM, et al. A systematic review of the impact of alcohol use disorders on HIV treatment outcomes, adherence to antiretroviral therapy and health care utilization. Drug Alcohol Depend. 2010;112(3):178–93.
Chang GC, et al. Hazardous alcohol use and HIV indicators in six african countries: results from the Population-based HIV Impact assessments, 2015–2017. J Int AIDS Soc. 2022;25(11):e26029.
Puryear SB, et al. Associations between alcohol use and HIV care cascade outcomes among adults undergoing population-based HIV testing in East Africa. AIDS. 2020;34(3):405–13.
Myers B, et al. Associations between patterns of Alcohol Use and viral load suppression Amongst Women living with HIV in South Africa. AIDS Behav. 2021;25(11):3758–69.
Vinikoor MJ et al. Intersection of alcohol use, HIV infection, and the HIV care continuum in Zambia: nationally representative survey. AIDS Care, 2022: p. 1–8.
Long JE, et al. Alcohol use and viral suppression in HIV-positive kenyan female sex workers on antiretroviral therapy. PLoS ONE. 2020;15(11):e0242817.
Wagman JA, et al. Hazardous alcohol use, antiretroviral therapy receipt, and viral suppression in people living with HIV who inject drugs in the United States, India, Russia, and Vietnam. AIDS. 2020;34(15):2285–94.
Arasteh K, Des DC, Jarlais. At-risk drinking and injection and sexual risk behaviors of HIV-positive injection drug users entering drug treatment in New York City. AIDS Patient Care STDS. 2009;23(8):657–61.
Chavez K, et al. Hazardous alcohol Use, Impulsivity, and HIV-Risk Behavior among HIV-Positive russian patients with a history of Injection Drug Use. Am J Addict. 2021;30(2):164–72.
Li L, et al. Alcohol Use, HIV Treatment Adherence, and sexual risk among people with a history of Injecting Drug Use in Vietnam. AIDS Behav. 2017;21(Suppl 2):167–73.
Ludwig-Barron NT, et al. Barriers and facilitators of HIV and hepatitis C care among people who inject drugs in Nairobi, Kenya: a qualitative study with peer educators. Harm Reduct J. 2021;18(1):133.
Bruce RD, et al. Lessons from Tanzania on the integration of HIV and tuberculosis treatments into methadone assisted treatment. Int J Drug Policy. 2014;25(1):22–5.
Kurth AE, et al. The opioid epidemic in Africa and its impact. Curr Addict Rep. 2018;5(4):428–53.
Monroe-Wise, A., et al., Peer-mediated HIV assisted partner services to identify and link to care HIV-positive and HCV-positive people who inject drugs: a cohort study protocol. BMJ Open, 2021. 11(4): p. e041083.
Steiner A, et al. Managing research and surveillance projects in real-time with a novel open-source eManagement tool designed for under-resourced countries. J Am Med Inform Assoc. 2016;23(5):916–23.
Papas RK, et al. Estimating alcohol content of traditional brew in Western Kenya using culturally relevant methods: the case for cost over volume. AIDS Behav. 2010;14(4):836–44.
National Center for Chronic Disease Prevention and Health. Excessive Alcohol Use. Center for Disease Control and Prevention; 2021.
National Institute on Alcohol Abuse and Alcoholism. Drinking levels defined. National Institutes of Health; 2022.
Patel NB. Khat (Catha edulis Forsk) - and now there are three. Brain Res Bull. 2019;145:92–6.
World Health Organization., Consolidated strategic information guidelines for HIV in the health sector. 2015.
UNAIDS. Global AIDS Response Progress Reporting 2016: construction of core indicators for monitoring the 2011 United Nations Political Declaration on HIV and AIDS. Geneva; 2016.
Centers for Disease Control and Prevention. Understanding the HIV Care Continuum. Atlanta, GA: CDC; 2017.
Joint United Nations Programme on HIV/AIDS. Miles to go: closing gaps, breaking barriers, righting injustices. UNAIDS: Geneva; 2018.
Kadere T, et al. Traditional tapping and distillation methods of coconut wine (mnazi) as practiced in the Coastal region of Kenya. African Journal of Food Agriculture Nutrition and Development; 2004.
Kibwage I, Maitai C, Mureithi I. Alcohol Content of Traditional Brews and Miti ni Dawa in Kenya. 1998, East and Central African Journal of Pharmaceutical Sciences. p. 54–57.
Giordano TP, et al. Patients referred to an urban HIV clinic frequently fail to establish care: factors predicting failure. AIDS Care. 2005;17(6):773–83.
Maughan-Brown B, et al. Poor rates of linkage to HIV care and uptake of treatment after home-based HIV testing among newly diagnosed 15-to-49 year-old men and women in a high HIV prevalence setting in South Africa. AIDS Care. 2021;33(1):70–9.
Heestermans T, et al. Determinants of adherence to antiretroviral therapy among HIV-positive adults in sub-saharan Africa: a systematic review. BMJ Glob Health. 2016;1(4):e000125.
National Authority for the Campaign Against Alcohol and Drug Abuse. Rapid Situation Assessment of drugs and substance abuse in Kenya. NACADA: Nairobi; 2017.
Pengpid S, Peltzer K. Alcohol use among adults in Kenya: Results from the National Non-Communicable Diseases Risk Factor survey. 2015, Journal of Psychology in Africa. p. 49–53.
World Health Organization. Global Status Report on Alcohol. WHO: Geneva; 2018.
Willis J. Soured Wine: The Development and Suppression of the Palm Wine Economy in Kenya, in Kenya Past and Present. p. 35–39.
Witkiewitz K, Litten RZ, Leggio L. Adv Sci Treat alcohol use disorder Sci Adv. 2019;5(9):eaax4043.
Chepkwony S, Chelule E, Barmao A. An investigation into prevalence and factors contributing to relapse among alcoholics In Selected Rehabilitation Centres in Nairobi County, Kenya. 2013, International Journal of Research and Development.
McGinnis KA, et al. Impact of behavioral and medication treatment for alcohol use disorder on changes in HIV-related outcomes among patients with HIV: a longitudinal analysis. Drug Alcohol Depend. 2020;217:108272.
Acknowledgements
We wish to acknowledge all partnering organizations and staff, particularly the peer educators for their contributions to data collection and the needle and syringe and methadone programs that worked with us (SAPTA, MEWA, The Omari Project, Reachout, Ngara Health Center, Mathari Referral Hospital). We would like to recognize the National AIDS and STI and Control Programme and Kenyatta National Hospital for their collaboration.
Funding
Collaborating authors are supported by a US National Institutes of Health (NIH) National Institute on Drug Abuse (NIDA) funded study (R01 DA043409). The content of this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Author information
Authors and Affiliations
Contributions
ND: conceptualization, data analysis and writing original draft. AMW, NLB, and CF: conceptualization, writing - review and editing. AMW, BG, BC, JH, CF: study design and data collection structure. AMW, BC, BG, BS, DB, EG, EK, EW, HK, LM, RB, SM, WS: writing - review and editing.
Corresponding author
Ethics declarations
Conflicts of Interest/Competing Interests
The authors declare that they have no competing interests.
Ethics Approval
All study procedures and materials were approved by the University of Washington Institutional Review Board (Seattle, WA, USA) and the Kenyatta National Hospital/University of Nairobi Ethical Review Committee (Nairobi, Kenya). This study was carried out in accordance with the Declaration of Helsinki.
Consent to Participate
Informed consent was obtained from all study participants.
Consent for Publication
Not applicable.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
DesLauriers, N., Sambai, B., Mbogo, L. et al. Alcohol use among people who inject drugs living with HIV in Kenya is associated with needle sharing, more new sex partners, and lower engagement in HIV care. AIDS Behav 27, 3970–3980 (2023). https://doi.org/10.1007/s10461-023-04113-0
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10461-023-04113-0